Skip to Main Navigation

Regional Vaccine Manufacturing and Development : Indonesia Country Case Study (Английский)

COVID-19 has had a devastating effect on the ASEAN region, which has recorded over 27 million cases of the virus. Despite rapid development of a range of COVID-19 vaccines using innovative technologies, access to these vaccines has been a challenge, with manufacturing mostly concentrated in the US and Europe for high-value mRNA vaccines, and China and India for traditional platforms and high-volume production. Countries with domestic COVID-19 vaccine...
Подробнее

ПОДРОБНАЯ ИНФОРМАЦИЯ

ФАЙЛЫ ДЛЯ СКАЧИВАНИЯ

ПОЛНЫЙ ОТЧЕТ

Официальная версия документа (может содержать подписи, и т.д.)

This document is being processed or is not available.